News

PPD has established a Rare Disease and Pediatric Center to oversee rare disease and pediatric-related drug development activities.

Worldwide Clinical Trials has announced the creation of its new Michael F. Murphy Clinical Research Methodology Fellowship Program.

With the U.K. poised to begin the process of leaving the European Union soon, many questions remain as to the specifics of pharma regulation and the wide-ranging effects of this departure.

TrialScope announced the launch of the Trial Results Summaries Portal, developed in partnership with AstraZeneca.

ERT announced that clinical development service provider, Premier Research, has selected ERT’s Trial Oversight suite as its trial management solution.

The Belgium-based EURORDIS symposium on rare diseases set out to realize dreams of accessible treatment for all, but the first day left much to be desired for this achievement.

PPD has entered into a collaboration with drug and medical device contract clinical development services provider Frenova Renal Research.

The TMF Reference Model has released a survey for industry professionals designed to provide insight for both paper and electronic trial document management.

INC Research announced the expansion of its Functional Service Provider (FSP) service offering

iCardiac Technologies has announced the launch of its new eCOA platform, QPoint.

OmniComm Systems and Bio-Optromics have reached an agreement with a CRO seeking to develop cancer treatments, for the use of their EDC and CTMS solutions.

Clinerion and ASUS Life have signed an agreement to deliver services for running clinical trials, clinical patient recruitment, market access and real-world evidence in Taiwan.

Homecare access to patients participating in clinical trials can prove beneficial for patients, sites and sponsors by incorporating the trial into their everyday lives.

ICON plc announced that the US FDA has awarded the company with a project validating three Patient Reported Outcomes instruments that will measure clinical endpoints in antibacterial drug trials.

The redundancy of process and documentation for activating trial sites has been an issue in the past as it can lead to delays in trial initiation. Rapid study startup can illuminate these inefficiencies by removing or reducing non-value tasks.

Updated employee announcements, business news, awards and recognition in the industry today.

Predictive modeling has allowed biopharma companies the opportunity to solve inaccurate, inefficient and misinformed site selection practices by leveraging big data.

The Clinical Trials Transformation Initiative (CTTI) has released recommendations to improve the quality and efficiency of clinical research studies used to develop antibacterial drugs for children.

Clinical technologies have the ability to streamline the daily processes of site staff and insure a more efficient clinical trial.